Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (421-430 of 448) with videos related to

Pageof 45
Sort By:
Journal of Scleroderma and Related Disorders|April 7, 2022
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definitionCosimo Bruni, Maya H Buch, Daniel E Furst, et al.
Annals of the Rheumatic Diseases|January 23, 2014
Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility geneSteven Gazal, Karim Sacre, Yannick Allanore, et al.
Arthritis Care & Research|November 5, 2011
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseJaap Fransen, Sindhu R Johnson, Frank van den Hoogen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
Annals of the Rheumatic Diseases|December 13, 2016
Update of EULAR recommendations for the treatment of systemic sclerosisOtylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosisEguzkine Ochoa, José-Ezequiel Martin, Shervin Assasi, et al.
RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.
Therapeutic Advances in Musculoskeletal Disease|March 5, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohortLiala Moschetti, Silvia Rovaris, Francesco Bonomi, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Rheumatology (Oxford, England)|May 13, 2017
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR groupVeronika K Jaeger, Oliver Distler, Britta Maurer, et al.
Pageof 45

Showing results (421-430 of 448) with videos related to

Sort By:
Pageof 45
Journal of Scleroderma and Related Disorders|April 7, 2022
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definitionCosimo Bruni, Maya H Buch, Daniel E Furst, et al.
Annals of the Rheumatic Diseases|January 23, 2014
Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility geneSteven Gazal, Karim Sacre, Yannick Allanore, et al.
Arthritis Care & Research|November 5, 2011
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseJaap Fransen, Sindhu R Johnson, Frank van den Hoogen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
Annals of the Rheumatic Diseases|December 13, 2016
Update of EULAR recommendations for the treatment of systemic sclerosisOtylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosisEguzkine Ochoa, José-Ezequiel Martin, Shervin Assasi, et al.
RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.
Therapeutic Advances in Musculoskeletal Disease|March 5, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohortLiala Moschetti, Silvia Rovaris, Francesco Bonomi, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Rheumatology (Oxford, England)|May 13, 2017
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR groupVeronika K Jaeger, Oliver Distler, Britta Maurer, et al.
Pageof 45